FDA Approved: ARAVA — Supplemental Application (sanofi-aventis U.S. LLC)

View source ↗

Summary

The FDA document concerns a supplemental application for ARAVA (leflunomide) by Sanofi-Aventis U.S. LLC, indicating a supplemental approval pathway.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ARAVA (leflunomide)

Snippet

SUPPL AP for ARAVA (LEFLUNOMIDE)